亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Drug Discovery Screening for Cyclophilin D Antagonists in Alzheimer's Disease

總結: Lead Inventors: Shi Du Yan, M.D.Problem or Unmet Need:Alzheimer's disease is the leading cause of neurodegenerative dementia, affecting over 35 million persons worldwide. The costs of care for this disease are enormous with direct healthcare costs estimated at $25 billion as well as indirect caregiver costs at $36.5 billion due to lost productivity. Unfortunately, few therapeutic options are available for treatment and prevention of this debilitating disease. New molecular targets for prevention and reversal of the dementia caused by Alzheimer's are needed for effective treatment. This technology demonstrates a novel drug screening assay in which compounds that activate the cyclophilin D pathway can be identified for the treatment of Alzheimer's disease. The authors of this technology have demonstrated that blockade of the cypophilin D protein protects against impaired memory and learning in animal models of Alzheimer's disease. Small molecules and/or biologic antibodies inhibiting cyclophilin D thus can be used for therapeutic treatment and prevention of Alzheimer's disease progression. The technology details methods for detection of compound affinity to the cyclophilin D complex as well as functional assays to determine the physiologic inhibition of cyclophilin cellular activity.

技術優勢: Novel molecular target Structural and functional screening assays Animal models available

技術應用: Drug discovery for Alzheimer's disease o Small molecule o Antibodies o Peptides o siRNA

詳細技術說明: This technology demonstrates a novel drug screening assay in which compounds that activate the cyclophilin D pathway can be identified for the treatment of Alzheimer's disease. The authors of this technology have demonstrated that blockade of t...

*Inquiry: Jerry Kokoshka Columbia Technology Ventures Tel: (212) 854-8444 Email: TechTransfer@columbia.edu

*Publications: Du et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nature Medicine. 2008 Oct;14(10):1097-105.

欲了解更多信息，請點擊這裡